AstraZeneca makes deal with Trump to lower drug prices and avoid tariffs
PositiveWorld Affairs

AstraZeneca has struck a deal with Donald Trump to lower drug prices by offering discounts on certain medicines to the Medicaid health plan. This agreement is significant as it aims to make prescription medications more affordable for Americans while also addressing tariff concerns from the administration. Such initiatives could lead to broader discussions on healthcare affordability and the role of pharmaceutical companies in the U.S.
— Curated by the World Pulse Now AI Editorial System